Back to Search Results
Study Complete
Sponsor ID
20000204

A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer

Sponsor ID
20000204
Clinicaltrials.gov ID
NCT00037518
EUCTIS ID
N/A
EudraCT ID
N/A
Contact Us

Study Details

This study will assess an investigational medication for patients with severe primary hyperparathyroidism or parathyroid cancer.

Additional Study Details

Phase
Phase 4
Product
cinacalcet hcl
Type
Interventional
Masking
None (Open Label)
Enrollment
46
Additional Study Details

Protocol Summary

Primary Outcome Measures
Not Available
Secondary Outcome Measures
Not Available

Study Documents

Study Synopsis
Available Language(s): English
Download Document(s)

Locations

No locations found.
Study Info
Age
18+ years
Condition
  • Hyperparathyroidism
    • Show more
  • Parathyroid Cancer
    • Sex
    All
    Trial Dates
    Apr 2001 - N/A
    Inclusion and Exclusion Criteria
    * Patients must have parathyroid carcinoma or severe primary hyperparathyroidism; * Abnormally elevated calcium levels above 12.5 mg/dL; * Not be pregnant or nursing; * Not have had any type of cancer other than parathyroid carcinoma within the last 5 years.